Comparison of near-infrared fluorescent deoxyglucose probes with different dyes for tumor diagnosis in vivo

Contrast Media and Molecular Imaging

Volumn 7, Issue 3, 2012, Pages 289-301

  Guo, Jing ^a,b   Du, Changli ^a   Shan, Lingling ^a   Zhu, Hongyan ^a   Xue, Bing ^a   Qian, Zhiyu ^c   Achilefu, Samuel ^d   Gu, Yueqing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c NANJING UNIVERSITY OF AERONAUTICS AND ASTRONAUTICS   (China)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Animal imaging; Cypate 2DG; Deoxyglucose; GLUT1; ICG Der 02 2DG; Near infrared

Indexed keywords

CYPATE; CYPATE 2 DEOXYGLUCOSE CONJUGATE; DEOXYGLUCOSE; FLUORESCENT DYE; GLUCOSE TRANSPORTER 1; INDOCYANINE GREEN; INDOCYANINE GREEN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACCUMULATION; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; HUMAN CELL; MOLECULAR PROBE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIAGNOSIS; TUMOR XENOGRAFT;

ANIMALS; CARBOCYANINES; COLORING AGENTS; DEOXYGLUCOSE; FEMALE; FLUORESCENT DYES; GLUCOSAMINE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; SPECTROSCOPY, NEAR-INFRARED; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84860384807     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.496     Document Type: Article

References (31)

1. Warburg O. On the origin of cancer cells. Science 1956; 123(3191): 309-314.
2. Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009; 121(1): 29-40.
3. Hediger MA, Rhoads DB. Molecular physiology of sodium-glucose cotransporters. Physiol Rev 1994; 74(4): 993-1026.
4. Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Schölmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C. Glut1 expression is increased in hepatocellular and promotes tumorigenesis. Am J Pathol 2009; 174(4): 1544-1552.
5. Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan CN, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of F-18-2-deoxy-2-fluoro-d-glucose. J Nucl Med 1978; 19(10): 1154-1161.
6. Yalcin A, Telang S, Clem B, Chesney J. Regulation of glucose metabolism by 6- phosphofructo-2-kinase/fructose-2, 6-bisphosphatases in cancer. Exp Mol Pathol 2009; 86(3): 174-179.
7. Song YS, Lee WW, Chung JH, Park SY, Kim YK, Kim SE. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung. Lung Cancer 2008; 61(1): 54-60.
8. van Baardwijk A, Dooms C, van Suylen RJ, Verbeken E, Hochstenbag M, Dehing-Oberije C, Rupa D, Pastorekova S, Stroobants S, Buell U, Lambin P, Vansteenkiste J, De Ruysscher D. The maximum uptake of 18F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1α and GLUT-1 in non-small cell lung cancer. Eur J Cancer 2007; 43(9): 1392-1398.
9. Suzuki H, Fukuyama R, Hasegawa Y, Tamaki T, Nishio M, Nakashima T, Tatematsu M. Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas. Oral Oncol 2009; 45(10): 891-897.
10. Mather S. Molecular imaging with bioconjugates in mouse models of cancer. Bioconjug Chem 2009; 20(4): 631-643.
11. Te Velde EA, Veerman TH, Subramaniam V, Ruers TH. The use of fluorescent dyes and probes in surgical oncology. Eur J Surg Oncol 2010; 36(1): 6-15.
12. Escobedo JO, Rusin O, Lim S, Strongin RM. NIR dyes for bioimaging applications. Curr Opin Chem Biol 2010; 14(1): 64-70.
13. Lewis JS, Achilefu S, Garbow JR, Laforest R, Welch MJ. Small animal imaging: current technology and perspectives for oncological imaging. Eur J Cancer 2002; 38(16): 2173-2188.
14. Rao JH, Dragulesu-Andrasi A, Yao HQ. Fluorescence imaging in vivo: recent advances. Curr Opin Biotechnol 2007; 18(1): 17-25.
15. Jobsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977; 198(4323): 1264-1267.
16. Zhang C, Liu T, Su YP, Luo S, Zhu Y, Tan X, Fan S, Zhang L, Zhou Y, Cheng T, Shi C. A near-infrared fluorescent heptamethine indocyanine dye with preferential tumor accumulation for in vivo imaging. Biomaterials 2010; 31(25): 6612-6617.
17. Terai T, Nagano T. Fluorescent probes for bioimaging applications. Curr Opin Chem Biol 2008; 12(5): 515-521.
18. Rasmussen JC, Tan IC, Marshall MV, Fife CE, Sevick-Muraca EM. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 2009; 20(1): 74-82.
19. O'Neil RG, Wu L, Mullani N. Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Mol Imag Biol 2005; 7(6): 388-392.
20. Lloyd PG, Hardin CD, Sturek M. Examining glucose transport in single vascular smooth muscle cells with a fluorescent glucose analog. Physiol Res 1999; 48(6): 401-410.
21. Chen Y, Zheng G, Zhang ZH, Blessington D, Zhang M, Li H, Liu Q, Zhou L, Intes X, Achilefu S, Chance B. Metabolism-enhanced tumor localization by fluorescence imaging: in vivo animal studies. Opt Lett 2003; 28(21): 2070-2072.
22. Zhang M, Zhang Z, Blessington D, Li H, Busch TM, Madrak V, Miles J, Chance B, Glickson JD, Zheng G. Pyropheophorbide 2-deoxyglucosamide: a new photosensitizer targeting glucose transporters. Bioconjug Chem 2003; 14(4): 709-714.
23. Ye YP, Bloch S, Kao J, Achilefu S. Multivalent carbocyanine molecular probes: synthesis and applications. Bioconjug Chem 2005; 16(1): 51-61.
24. Cheng Z, Levi J, Xiong Z, Gheysens O, Keren S, Chen X, Gambhir SS. Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem 2006; 17(3): 662-669.
25. Kovar JL, Volcheck W, Sevick-Muraca E, Simpson MA, Olive DM. Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem 2009; 384(2): 254-262.
26. Welch RD, Gorski J. Regulation of glucose transporters by estradiol in the immature rat uterus. Endocrinology 1999; 140(8): 3602-3608.
27. Cheng CM, Cohen M, Wang J, Bondy CA. Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex. FASEB J 2001; 15(6): 907-915.
28. Rivenzon-segal D, Boldin-adamsky S, Seger D, Seger R, Degani H. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer 2003; 107: 177-182.
29. Chen HY, Zhang J, Qian ZY, Liu F, Chen XY, Hu YZ, Gu YQ. In vivo non-invasive optical imaging of temperature-sensitive co-polymeric nanohydrogel. Nanotechnology 2008; 19: 185707-185717.
30. Liu F, Deng DW, Chen XY, Qian ZY, Achilefu S, Gu YQ. Folate-polyethylene glycol conjugated near-infrared fluorescence probe with high targeting affinity and sensitivity for in vivo early tumor diagnosis. Mol Imag Biol 2010; 12(6): 595-607.
31. Achilefu S, Dorshow RB, Bugaj JE, Rajagopalan R. Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest Radiol 2000; 35(8): 479-485.